相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liposomes and Extracellular Vesicles as Drug Delivery Systems: A Comparison of Composition, Pharmacokinetics, and Functionalization
Luke van der Koog et al.
ADVANCED HEALTHCARE MATERIALS (2022)
Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy
Seyedeh Alia Moosavian et al.
SEMINARS IN CANCER BIOLOGY (2021)
Copper metabolism as a unique vulnerability in cancer
Vinit C. Shanbhag et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2021)
An Arm and a Leg: The Rising Cost of Cancer Drugs and Impact on Access
Natasha B. Leighl et al.
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting (2021)
Disulfiram: a novel repurposed drug for cancer therapy
Chen Lu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2021)
Seesaw conformations of Npl4 in the human p97 complex and the inhibitory mechanism of a disulfiram derivative
Man Pan et al.
NATURE COMMUNICATIONS (2021)
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
Ammar Said Suliman et al.
PHARMACEUTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells
Kubra Solak et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics
Filip Michniewicz et al.
CHEMMEDCHEM (2021)
Kinase drug discovery 20 years after imatinib: progress and future directions
Philip Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
Xiaojie Liu et al.
FRONTIERS IN ONCOLOGY (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
The rediscovery of platinum-based cancer therapy
Sven Rottenberg et al.
NATURE REVIEWS CANCER (2021)
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
Francesca Rolle et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
Stephanie Blockhuys et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways
Yiqiu Li et al.
CANCERS (2020)
Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
Dusana Majera et al.
CELLS (2020)
Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry
Xinling Lu et al.
TALANTA (2020)
Life, death, and autophagy in cancer: NF-κB turns up everywhere
Daniela Verzella et al.
CELL DEATH & DISEASE (2020)
Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways
Yaqi Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Copper homeostasis: Emerging target for cancer treatment
Yueqin Li
IUBMB LIFE (2020)
Epithelial-mesenchymal transition and metastasis of colon cancer cells induced by the FAK pathway in cancer-associated fibroblasts
Xuefeng Xuefeng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
Nur Aininie Yusoh et al.
CHEMMEDCHEM (2020)
Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma
Hirofumi Yoshino et al.
PLOS ONE (2020)
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
Pierre Lelievre et al.
CANCERS (2020)
Non-genetic mechanisms of therapeutic resistance in cancer
Jean-Christophe Marine et al.
NATURE REVIEWS CANCER (2020)
Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors
Parikshit Banerjee et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis
Vinit Shanbhag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
Zhi Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents
Elmira Ekinci et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase
Zdenek Skrott et al.
ONCOGENE (2019)
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Silvia Schmidtova et al.
CANCERS (2019)
Inhibitory effect on ovarian cancer ALDH plus stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation
Fang Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Mohammad Najlah et al.
PHARMACEUTICS (2019)
Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel
Xiao Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways
Yi Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts
Hanumantha Rao Madala et al.
ONCOTARGET (2018)
Development of a copper-clioquinol formulation suitable for intravenous use
Moe Wehbe et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line
Kate Butcher et al.
BMC CANCER (2018)
Targeting ALDH2 with disulfiram/copper reverses the resistance of cancer cells to microtubule inhibitors
Nan-nan Wang et al.
EXPERIMENTAL CELL RESEARCH (2018)
Disulfiram/copper targets stem cell-like ALDH+ population of multiple myeloma by inhibition of ALDH1A1 and Hedgehog pathway
Na Jin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Disulfiram-loaded mixed nanoparticles with high drug-loading and plasma stability by reducing the core crystallinity for intravenous delivery
Xuezhi Zhuo et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2018)
mPEG5k-b-PLGA2k/PCL3.4k/MCT Mixed Micelles as Carriers of Disulfiram for Improving Plasma Stability and Antitumor Effect in Vivo
Linlin Miao et al.
MOLECULAR PHARMACEUTICS (2018)
Disulfiram combats cancer via crippling valosin-containing protein/p97 segregase adaptor NPL4
Nan Ding et al.
TRANSLATIONAL CANCER RESEARCH (2018)
Trace Element and Heavy Metal Levels in Colorectal Cancer: Comparison Between Cancerous and Non-cancerous Tissues
Masoudreza Sohrabi et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2018)
Changes in the Serum Levels of Trace Elements Before and After the Operation in Thyroid Cancer Patients
Abdulkerim Kasim Baltaci et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2017)
Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer
Mohammad Najlah et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Polymeric micelles: Basic research to clinical practice
Anand S. Deshmukh et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Polymeric nanoparticles: Promising platform for drug delivery
Khalid M. El-Say et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer
Veronica Vella et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
Zhipeng Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Zdenek Skrott et al.
NATURE (2017)
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-kB and Nrf2
Bing Xu et al.
CELL DEATH & DISEASE (2017)
Combination of Fe/Cu -chelators and docosahexaenoic acid: an exploration for the treatment of colorectal cancer
Nanhui Yu et al.
ONCOTARGET (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
Magdalena Stepien et al.
CARCINOGENESIS (2017)
Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells
Yoon-Jae Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Sandeo Prasad et al.
CANCER LETTERS (2017)
Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy
Wantong Song et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Assessment of serum copper, iron and immune complexes in potentially malignant disorders and oral cancer
Ritu Tiwari et al.
BRAZILIAN ORAL RESEARCH (2016)
Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations
Hamidreza Fasehee et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
Hot melt extruded and injection moulded disulfiram-loaded PLGA millirods for the treatment of glioblastoma multiforme via stereotactic injection
Christopher McConville et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Drug repurposing in oncology-patient and health systems opportunities
Francesco Bertolini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
Damiano Cosimo Rigiracciolo et al.
ONCOTARGET (2015)
The cytotoxic mechanisms of disulfiram and copper(II) in cancer cells
Patricia Erebi Tawari et al.
TOXICOLOGY RESEARCH (2015)
Analysis of serum levels of 15 trace elements in breast cancer patients in Shandong, China
Xiao Ding et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2015)
A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells
Joan Fernando et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Molecular Mechanisms Underlying the Divergent Roles of SPARC in Human Carcinogenesis
Ganji Purnachandra Nagaraju et al.
CARCINOGENESIS (2014)
Oxidizing to death Disulfiram for cancer cell killing
Ansgar Bruening et al.
CELL CYCLE (2014)
Aldehyde dehydrogenases in cancer: an opporunity for biomaker and drug development?
Klaus Pors et al.
DRUG DISCOVERY TODAY (2014)
Multi-targeted inhibition of tumor growth and lung metastasis by redox-sensitive shell crosslinked micelles loading disulfiram
Xiaopin Duan et al.
NANOTECHNOLOGY (2014)
Copper is required for oncogenic BRAF signalling and tumorigenesis
Donita C. Brady et al.
NATURE (2014)
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
Tetsuhiro Chiba et al.
PLOS ONE (2014)
Memo Is a Copper-Dependent Redox Protein with an Essential Role in Migration and Metastasis
Gwen MacDonald et al.
SCIENCE SIGNALING (2014)
Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
Peng Liu et al.
ONCOTARGET (2014)
Serum levels of ferritin, copper, and zinc in patients with oral cancer
Hamed Mortazavi et al.
Biomedical Journal (2014)
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2013)
D-penicillamine and other low molecular weight thiols: Review of anticancer effects and related mechanisms
Saurabh Wadhwa et al.
CANCER LETTERS (2013)
The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease
Natalie K. Y. Wee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells
Tao Huang et al.
ONCOLOGY REPORTS (2013)
P38/NF-κB/Snail Pathway Is Involved in Caffeic Acid-Induced Inhibition of Cancer Stem Cells-Like Properties and Migratory Capacity in Malignant Human Keratinocyte
Ye Yang et al.
PLOS ONE (2013)
Bioavailable copper modulates oxidative phosphorylation and growth of tumors
Seiko Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Heavy and Trace Metals in Carcinoma of the Gallbladder
Somprakas Basu et al.
WORLD JOURNAL OF SURGERY (2013)
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
P. Liu et al.
BRITISH JOURNAL OF CANCER (2012)
Copper levels in patients with hematological malignancies
Georgia D. Kaiafa et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Gallium-containing anticancer compounds
Christopher R. Chitambar
FUTURE MEDICINAL CHEMISTRY (2012)
Serum total oxidant/antioxidant status and trace element levels in breast cancer patients
Jia-Fu Feng et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
Joanna Triscott et al.
ONCOTARGET (2012)
Lysyl Oxidase, Extracellular Matrix Remodeling and Cancer Metastasis
Qian Xiao et al.
CANCER MICROENVIRONMENT (2012)
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
N. C. Yip et al.
BRITISH JOURNAL OF CANCER (2011)
Combined effects of serum trace metals and polymorphisms of CYP1A1 or GSTM1 on non-small cell lung cancer: A hospital based case-control study in China
Yongtang Jin et al.
CANCER EPIDEMIOLOGY (2011)
Disulfiram, and Disulfiram Derivatives as Novel Potential Anticancer Drugs Targeting the Ubiquitin Proteasome System in Both Preclinical and Clinical Studies
F. R. Kona et al.
CURRENT CANCER DRUG TARGETS (2011)
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo et al.
CANCER LETTERS (2010)
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Michael Frezza et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion
Yadi Wu et al.
CANCER CELL (2009)
COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION
Lydia Finney et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Role of Copper in Angiogenesis and Its Medicinal Implications
Huiqi Xie et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Copper Regulation of Hypoxia-Inducible Factor-1 Activity
Wenke Feng et al.
MOLECULAR PHARMACOLOGY (2009)
The value of proteasome inhibition in cancer
Boris Cvek et al.
DRUG DISCOVERY TODAY (2008)
Phosphatase-mediated crosstalk between MAPK signalling pathways in the regulation of cell survival
Melissa R. Junttila et al.
FASEB JOURNAL (2008)
Ni(II), Cu(II), and Zn(II) Diethyldithiocarbamate Complexes Show Various Activities Against the Proteasome in Breast Cancer Cells
Boris Cvek et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
S. Julien et al.
ONCOGENE (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation
Anshul Gupte et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:: potential involvement of ZEB-1 and ZEB-2
H. L. Chua et al.
ONCOGENE (2007)
Distribution of trace metal concentrations in paired cancerous and non-cancerous human stomach tissues
Mehmet Yaman et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Targeting of nuclear Factor-kappa B and proteasome by dithiocarbamate complexes with metals
B. Cvek et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram
H Lövborg et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The status of disulfiram - A half of a century later
Jesse J. Suh et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Copper-dependent activation of hypoxia-inducible factor (HIF)-1:: implications for ceruloplasmin regulation
F Martin et al.
BLOOD (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells
DZ Cen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Disulfiram-mediated inhibition of NF-κB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines
WG Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Constitutive nuclear factor-kappa B mRNA, protein overexpression and enhanced DNA-binding activity in thymidylate synthase inhibitor-resistant tumour cells
W Wang et al.
BRITISH JOURNAL OF CANCER (2003)
Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation
GJ Brewer
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2003)
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition
M Moriguchi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Analysis of serum copper and zinc concentrations in cancer patients
M Zowczak et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2001)
分享论文
